Diabetes Insipidus Can Occur After Stopping Vasopressin

This article originally appeared here.
Share this content:
Diabetes Insipidus Can Occur After Stopping Vasopressin
Diabetes Insipidus Can Occur After Stopping Vasopressin

FRIDAY, Sept. 22, 2017 (HealthDay News) -- Although rare, diabetes insipidus (DI) can occur following discontinuation of vasopressin infusion for septic shock, according to a case study published online Sept. 11 in the Journal of Clinical Pharmacy & Therapeutics.

H. Rana, M.D., from the Montefiore Medical Center in Bronx, N.Y., and colleagues present a case of DI following discontinuation of vasopressin infusion for septic shock.

The authors describe a 54-year-old man who presented with pneumonia progressing to septic shock, requiring norepinephrine and vasopressin for refractory hypotension. On three separate occasions the patient developed polyuria and severe hypernatremia upon discontinuation of vasopressin, with prompt recovery upon its resumption.

"The occurrence of DI upon the discontinuation of vasopressin infusion in critically ill patients appears to be rare, but its incidence may be underestimated due to a paucity of published reports. Patients with acute neurologic or neurosurgical conditions, and patients in septic shock, represent all cases reported to date," the authors write. "The actual incidence of this phenomenon, as well as its underlying mechanism, remains to be elucidated."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Doctors Urged to Speak With Patients About Firearms

Doctors Urged to Speak With Patients About Firearms

Making a public commitment is encouraged as a positive action that physicians can take

Machine Learning Model Predicts Risk of Upgrade to Breast CA

Machine Learning Model Predicts Risk of Upgrade to ...

Model can predict risk of upgrade of high-risk breast lesions to cancer using traditional, text features

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

Glycemic Control Up With Oral Semaglutide in Type ...

Phase 3 studies next to assess longer-term/clinical outcomes, safety

is free, fast, and customized just for you!

Already a member?

Sign In Now »